Proposing a treatment plan strategy for VMAT plans in the event of unavailability of a source linear accelerator or other compatible linacs at a radiotherapy center
PDF (Język Polski)


Simultaneous Integrated Boost SIB
prostate cancer
linear accelerator

How to Cite

Bąk, O., Kijeska, W., Kosmowska, J., Pańczyszyn, M., & Skrobała, A. (2022). Proposing a treatment plan strategy for VMAT plans in the event of unavailability of a source linear accelerator or other compatible linacs at a radiotherapy center. Letters in Oncology Science, 19(1).


The study aimed to propose a strategy for dealing with a SIB treatment plan performed using VMAT (Volumetric Modulated Arc Therapy) dynamic technique in the case of unavailability of the source device and no compatible linear accelerator in the center. The study was based on 20 patients with prostate cancer treated with simultaneous integrated boost (SIB) with VMAT treatment plan for two or three full arches. Subsequently, 7-field IMRT (Intensity Modulated Radiation Therapy) replacement plans were made based on the original treatment plans. For the VMAT and IMRT plans, a beam of 6 MeV energy was used with a set dose of 67,5 Gy for PTV (Planning Target Volume) of the prostate and 45 Gy for PTV of the nodes in 30 fractions. The dose differences between VMAT and IMRT technique for PTV volume s did not exceed the acceptable limit - of 2%. For critical organs, the difference in dose was within the tolerance doses described in the report QUANTEC (Quantitative Analyses of Normal Tissue Effects in the Clinic). Conformity index CI (Conformity Index) values for plans in VMAT technique were between 0,53 and 0,58, and for plans in IMRT, between 0,49 and 0,54. The total number of monitor units for the VMAT technique was between 626 and 777 MU, for the IMRT plan the minimum number of MU was 2013 MU, and the maximum was 2766 MU. Studies have shown that for PTV, despite the minor differences obtained for doses in critical organs, while falling within the criteria for tolerable doses and longer irradiation times, the SIB-IMRT technique can be used as an alternative treatment plan for the patient without compromising the quality of treatment.
PDF (Język Polski)


Ambroggi M, Biasini C, Del Giovane C, et al. Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature. Oncologist. 2015;20:1378-85

Raport. Radioterapia w Polsce w świetle zmian systemowych – analiza i rekomendacje 2021., dostęp 13.10.2022 r.

Rozporządzenie Ministra Zdrowia z dnia 14 października 2021 r. w sprawie minimalnych wymagań dla jednostek ochrony zdrowia prowadzących działalność związaną z narażeniem w celach medycznych, polegającą na udzielaniu świadczeń zdrowotnych z zakresu radioterapii i leczenia za pomocą produktów radiofarmaceutycznych, Dziennik Ustaw 2021 poz. 1890.

Wang L, Lu B, He M, et al. Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Front Public Health. 2022;10:811044.

Raport roczny. Nowotwory złośliwe w Polsce w 2019 roku. Narodowy Instytut Onkologii,, dostęp 13.10.2022 r.

ICRU Report 50. Prescribing, Recording and Reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements, 1993.

ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements, 1999.

Low DA, Harms WB, Mutic S, et al. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25:656–61.

IAEA: TRS-398 Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry based on Standards of Absorbed Dose to Water, 12, International Atomic Energy Agency, IAEA, 2006.

Charmacińska M, Skrobała A, Styś S, et al. Propozycja Strategii Postępowania z planami leczenia dla akceleratorów o różnej konstrukcji kolimatora. Inżynier i Fizyk Medyczny. 2020;5; 9:309-15.

Bentzen S.M, Constine L.S, Deasy J, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues, Int J Radiat Oncol Biol Phys, 2010;76:3-9.

Onal C, Sonmez S, Erbay G, et al. Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy. Journal of Radiotherapy in Practice 20:1-11.

Mukhtar R, Butt S, Rafaye M.A, et al. An institutional review: dosimetry comparison between simultaneous integrated boost IMRT and VMAT for prostate cancer. Journal of Radiotherapy in Practice 2020:1-11.

Mellon E.A, Javedan K, Strom T.J, et al. A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer Pract Radiat Oncol, 2015;5:11-5.

Ost P, Speleers B, De Meerleer G, et al. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study. Int J Radiat Oncol Biol Phys. 2011;79:920-6.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2022 Letters in Oncology Science


Download data is not yet available.